Wound healing: A paradigm for lumen narrowing after arterial reconstruction

被引:91
作者
Geary, RL
Nikkari, ST
Wagner, WD
Williams, JK
Adams, MR
Dean, RH
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Surg, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Comparat Med, Winston Salem, NC 27157 USA
[3] Tampere Univ, Sch Med, Dept Med Biochem, FIN-33101 Tampere, Finland
关键词
D O I
10.1016/S0741-5214(98)70296-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: The intimal hyperplasia hypothesis that equates lumen narrowing after arterial injury with intimal mass has recently been challenged. Evidence has emerged to suggest that lumen narrowing is caused in large part by changes in artery wall geometry rather than intimal mass per se. We have begun to explore this hypothesis in a unique nonhuman primate model of atherosclerosis. Methods: Monkeys who were fed an atherogenic diet for 3 to 5 years underwent experimental angioplasty of the left iliac artery. The contralateral iliac artery served as an intraanimal control. Arteries were removed 2, 4, 7, 14, 28, or 112 days later for analysis (6 or 13 per time point). Angioplasty dilated arteries by fracturing atheroma and stretching or tearing the media. Cross-sections of injured arteries were analyzed for expression of extracellular matrix components and cell surface integrins that are important in wound healing. Antibodies, riboprobes, or histochemical stains specific for fibrin, hyaluronan, versican (chondroitin sulfate-containing proteoglycan), procollagen-I, elastin, and the alpha(2) beta(1) and alpha(V) beta(3) integrins were used. Results: A thin mural thrombus was seen at sites of denudation and plaque fracture (days 2 to 7). This provisional matrix was invaded by leukocytes (days 2 to 4) and cx-actin-positive smooth muscle cells (SMCs; days 4 to 7). Thrombus was replaced by SMCs expressing hyaluronan and the associated versican proteoglycans (day 14). Versican was expressed throughout the neointima as it enlarged (day 28), but expression later subsided (day 112). Procollagen-I expression initially increased in the adventitia (day 4) and then in the forming neointima (day 14). Procollagen-I expression was found to persist within the adventitia and in the neointima in SMCs nearest the lumen (days 28 to 112). Elastin staining was prominent within the mature neointima (day 112) but not at earlier time points. Integrin expression also increased within the injured artery wall. alpha(V) beta(3) staining (fibrin[ogen] receptor) increased in the injured media (days 2 to 7) and was then seen throughout the early neointima (day 7). Low level expression of alpha(V) beta(3) subsequently persisted within the forming neointima (day 28). alpha(2) beta(1) (collagen receptor) expression increased in the neointima in SMCs nearest the lumen (day 28). Conclusions: Lumen narrowing after angioplasty in this model of atherosclerosis is caused largely by decreased artery wall diameter. The pattern of matrix and integrin expression within the injured artery wall is in many ways analogous to that of healing wounds. These observations suggest that tissue contraction may play a role in lumen narrowing at sites of arterial reconstruction. Strategies to inhibit wound contraction may prove effective in preventing restenosis.
引用
收藏
页码:96 / 106
页数:11
相关论文
共 44 条
[1]   USE OF A MONOCLONAL-ANTIBODY DIRECTED AGAINST THE PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR IN HIGH-RISK CORONARY ANGIOPLASTY [J].
CALIFF, RM ;
SHADOFF, N ;
VALETT, N ;
BATES, E ;
GALEANA, A ;
KNOPF, W ;
SHAFTEL, J ;
BENDER, MJ ;
AVERSANO, T ;
RAQUENO, J ;
GURBEL, P ;
COWFER, J ;
COHEN, M ;
CROSS, P ;
BITTL, J ;
EDDINGS, K ;
TAYLOR, M ;
DEROSA, K ;
HATTEL, L ;
COOPER, L ;
ESHELMAN, B ;
FINTEL, D ;
NIEMYSKI, P ;
KLEIN, L ;
KENNEDY, H ;
THORNTON, T ;
KEREIAKES, D ;
MARTIN, L ;
ANDERSON, L ;
HIGBY, N ;
ELLIS, S ;
BREZINA, K ;
GEORGE, B ;
CHAPEKIS, A ;
SMITH, D ;
ANWAR, A ;
GERBER, TL ;
PRITCHARD, GL ;
MYLER, R ;
SHAW, R ;
MURPHY, M ;
WARD, K ;
MADIGAN, NP ;
BLANKENSHIP, J ;
HALBERT, M ;
FLANAGAN, C ;
TANNENBAUM, M ;
POLICH, M ;
STEVENSON, C ;
TCHENG, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (14) :956-961
[2]  
CATERSON B, 1985, FED PROC, V44, P386
[4]   INHIBITION OF NEOINTIMAL HYPERPLASIA BY BLOCKING ALPHA(V)BETA(3), INTEGRIN WITH A SMALL PEPTIDE ANTAGONIST GPENGRGDSPCA [J].
CHOI, ET ;
ENGEL, L ;
CALLOW, AD ;
SUN, SP ;
TRACHTENBERG, J ;
SANTORO, S ;
RYAN, US .
JOURNAL OF VASCULAR SURGERY, 1994, 19 (01) :125-134
[5]   REMODELING OF CORONARY-ARTERIES IN HUMAN AND NONHUMAN-PRIMATES [J].
CLARKSON, TB ;
PRICHARD, RW ;
MORGAN, TM ;
PETRICK, GS ;
KLEIN, KP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (04) :289-294
[6]   SUPPRESSION BY HEPARIN OF SMOOTH-MUSCLE CELL-PROLIFERATION IN INJURED ARTERIES [J].
CLOWES, AW ;
KARNOWSKY, MJ .
NATURE, 1977, 265 (5595) :625-626
[8]   LOW-MOLECULAR-WEIGHT HEPARIN IN PREVENTION OF RESTENOSIS AFTER ANGIOPLASTY - RESULTS OF ENOXAPARIN RESTENOSIS (ERA) TRIAL [J].
FAXON, DP ;
SPIRO, TE ;
MINOR, S ;
COTE, G ;
DOUGLAS, J ;
GOTTLIEB, R ;
CALIFF, R ;
DOROSTI, K ;
TOPOL, E ;
GORDON, JB ;
OHMEN, M ;
RAIZNER, A ;
PAR, T ;
CURRIER, J ;
HANKIN, B .
CIRCULATION, 1994, 90 (02) :908-914
[9]   A RANDOMIZED COMPARISON OF CORONARY-STENT PLACEMENT AND BALLOON ANGIOPLASTY IN THE TREATMENT OF CORONARY-ARTERY DISEASE [J].
FISCHMAN, DL ;
LEON, MB ;
BAIM, DS ;
SCHATZ, RA ;
SAVAGE, MP ;
PENN, I ;
DETRE, K ;
VELTRI, L ;
RICCI, D ;
NOBUYOSHI, M ;
CLEMAN, M ;
HEUSER, R ;
ALMOND, D ;
TEIRSTEIN, PS ;
FISH, RD ;
COLOMBO, A ;
BRINKER, J ;
MOSES, J ;
SHAKNOVICH, A ;
HIRSHFELD, J ;
BAILEY, S ;
ELLIS, S ;
RAKE, R ;
GOLDBERG, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (08) :496-501
[10]   GRANULATION TISSUE AS A CONTRACTILE ORGAN - STUDY OF STRUCTURE AND FUNCTION [J].
GABBIANI, G ;
RYAN, GB ;
STATKOV, PR ;
HIRSCHEL, BJ ;
MAJNO, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1972, 135 (04) :719-&